Canaccord reiterates Neurogene stock rating on Rett syndrome data

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Canaccord cuts Definium Therapeutics stock price target on share count Hisse Senetleri 0 1
A Canaccord reiterates AtriCure stock Buy rating after FDA clearance Hisse Senetleri 0 1
A Canaccord cuts Concentrix stock price target on guidance reduction Hisse Senetleri 0 1
A Canaccord reiterates Alnylam stock Buy rating after RNAi event Hisse Senetleri 0 1
A Canaccord reiterates Holley stock buy rating on dealer survey Hisse Senetleri 0 3
A Canaccord Genuity reiterates Buy rating on TalkSpace stock with $6 target Hisse Senetleri 0 29
A Canaccord Genuity reiterates Buy rating on Hillman Solutions stock Hisse Senetleri 0 29
A Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target Hisse Senetleri 0 28

Benzer konular

Üst